AstraZeneca Vietnam receives special BritCham award

Wednesday, Jun 14, 2023 21:40

Representatives of AstraZeneca Vietnam receive the first-ever British Chamber of Commerce's (BritCham) 50th Anniversary Recognition award for its contribution in Viet Nam. — Photo courtesy of AstraZeneca Vietnam

AstraZeneca Vietnam has been recently honoured with the British Chamber of Commerce's (BritCham) 50th Anniversary Recognition award to acknowledge the company's unwavering commitment to innovation, sustainability, and its profound impact on Viet Nam's healthcare sector.

This first-ever award recognition comes as part of the celebration of 50 years of bilateral relations between the UK and Viet Nam.

"As a global biopharmaceutical company with British-Swedish heritage and nearly three decades supporting Viet Nam’s health system, we are driven by a shared purpose to build a healthier future and make a lasting impact through innovation and sustainability. We are immensely proud to contribute to the UK-Viet Nam partnership and will continue to bring the advances of Britain’s life sciences industry to create positive change for the people in Viet Nam," said Nitin Kapoor, chairman and general director of AstraZeneca Vietnam and Asia Area Frontier Markets.

AstraZeneca was ranked number one in Invention of Idea Pharma’s 2023 Pharmaceutical Innovation and Invention Index, and has been the leader in terms of industry-sponsored clinical trials in Viet Nam.

A significant percentage of the US$360 million which the company has committed to invest in Viet Nam until 2030 has been dedicated to research and development to further strengthen the country's research capabilities and increase patients’ early access to new medicines.

In addition, AstraZeneca Vietnam's commitment to sustainability is evident in its initiatives to promote access to healthcare, protect the environment, and uphold ethics and transparency. As part of the company’s impactful partnerships with the Ministry of Health and healthcare organisations, AstraZeneca has run various community investment programmes to promote disease awareness, prevention, and early detection.

In order to support Viet Nam’s sustainable development and net zero strategy, AstraZeneca recently announced a $50 million investment into Viet Nam to plant 22.5 million trees over the next five years as part of the company’s global AZ Forest programme. — VNS

Comments (0)